Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Preliminary Phase 2 Results Demonstrate Engraftment with Minimal Neutropenia with MGTA-456, a CD34 + Expanded Cord Blood (CB) Product in Patients Transplanted for Inherited Metabolic Disorders (IMD)

Paul Orchard, MD, Glen D. Raffel, MD, Carolyn H Condon, MPH, Catherine A Monaghan, Demetra Vernet, Suzanne Tracey Sheirr, Jennifer Braun, RN BSN, Ryan Shanley, M.S, Troy C Lund, MD MS, PhD, Anthony E. Boitano, PhD, Michael P. Cooke, PhD, John C Davis, MD MPH, John E. Wagner, MD

Blood (2018) 132 (Supplement 1): 3467.

https://doi.org/10.1182/blood-2018-99-115102

Published: 2018

Journal Articles

Prognostic Relevance of Monocytopenia and Lymphocyte-to-Monocyte Ratio in Primary Myelodysplastic Syndromes

Lyla Saeed, MBBS, Mrinal M Patnaik, MBBS, Kebede H. Begna, MD, Aref Al-Kali, MD, Mark R Litzow, MD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MBBS, Ayalew Tefferi, MD

Blood (2016) 128 (22): 1996.

https://doi.org/10.1182/blood.V128.22.1996.1996

Published: 2016

Journal Articles

Inhibition of the Histone Demethylase LSD1 Combined with Caloric Restriction or IGF1/Insulin Inhibition Leads to Durable Responses in a Preclinical Model of Acute Myeloid Leukemia

Blood (2015) 126 (23): 459.

https://doi.org/10.1182/blood.V126.23.459.459

Published: 2015

Journal Articles

Defective WNT Signaling and Genetic Profile Of Endothelial Cells In Patients With Low Risk Myelodysplastic Syndromes Suggest a Contribution Of Vascular Niches To Myelodysplasia

Luciana Teofili, Maurizio Martini, M.D., Eugenia Rosa Nuzzolo, Sara Capodimonti, Alessandra Cocomazzi, Maria Grazia Iachininoto, Maria Teresa Voso, M.D., Gina Zini, Luigi M. Larocca, M.D.

Blood (2013) 122 (21): 860.

https://doi.org/10.1182/blood.V122.21.860.860

Published: 2013

Journal Articles

Benefit of Extended Maintenance Therapy for Venous Thromboembolism with Dabigatran Etexilate Is Maintained Over 1 Year of Post-Treatment Follow-up

Sam Schulman, MD, PhD, David Baanstra, MD, Henry Eriksson, MD, Samuel Z. Goldhaber, MD, Ajay Kakkar, MD, Clive Kearon, MD, PhD, Sebastian Schellong, MD, Jeffrey Friedman, MD

Blood (2012) 120 (21): 21.

https://doi.org/10.1182/blood.V120.21.21.21

Published: 2012

Journal Articles

A Decision Analysis of Unrelated Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia In First Remission Who Lack An HLA-Matched Sibling

Blood (2010) 116 (21): 3527.

https://doi.org/10.1182/blood.V116.21.3527.3527

Published: 2010

Journal Articles

Combination of the KSP Inhibitor ARRY-520 with Bortezomib or Revlimid Causes Sustained Tumor Regressions and Significantly Increased Time to Regrowth in Models of Multiple Myeloma.

Richard Woessner, Brian Tunquist, April Cox, Sumeet Rana, Duncan Walker, Patrice A. Lee

Blood (2009) 114 (22): 2858.

https://doi.org/10.1182/blood.V114.22.2858.2858

Published: 2009

Journal Articles

Results of Bone Marrow Examinations in Patients with Chronic Immune Thrombocytopenic Purpura Treated with Eltrombopag.

Mansoor N. Saleh, MD, James B. Bussel, MD, Oliver Meyer, Henrik Frederiksen, Diane Johnni, Manuel Aivado, Andres Brainsky

Blood (2009) 114 (22): 1326.

https://doi.org/10.1182/blood.V114.22.1326.1326

Published: 2009

Journal Articles

Venous Thromboembolism Risk in Stroke Patients Receiving Extended-Duration Enoxaparin Prophylaxis: Sub-Analysis of the EXCLAIM Study

Alexander GG Turpie, MD, Russell D Hull, MBBS, Sebastian M Schellong, MD, Victor F Tapson, MD, Manuel Monreal, MD, Meyer Michel Samama, MD, PharmD, Roger D Yusen, MD, MPH

Blood (2008) 112 (11): 433.

https://doi.org/10.1182/blood.V112.11.433.433

Published: 2008

Journal Articles

Delayed Response to Lenalidomide in International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS).

Erev E. Tubb, MD, Emmanuel C. Besa, MD, Aristoteles Giagounidis, MD, Gustavo A. Fonseca, MD

Blood (2007) 110 (11): 1447.

https://doi.org/10.1182/blood.V110.11.1447.1447

Published: 2007

Journal Articles

Beneficial Effect of Zinc Supplementation on Oxidative Stress, Cytokines, and NF-κB DNA Binding in Sickle Cell Disease Patients.

Bin Bao, PhD, Ananda Prasad, MD, Ph.D, Frances W.J. Beck, Ph.D., Paul Swerdlow, MD, Anupam Suneja, MD

Blood (2006) 108 (11): 1203.

https://doi.org/10.1182/blood.V108.11.1203.1203

Published: 2006

Journal Articles

A New Predictive and Prognostic Marker for De Novo AML: Peripheral Blood CD34 (pCD34) Count at Recovery Following Remission Induction (RI) Therapy (Supp. by Ankara University-2003-0809114).

Mutlu Arat, MD, Pervin Topcuoglu, MD, Meltem K. Yuksel, MD, Klara Dalva, MD, Gulhis Gultekin, MD, Gunhan Gurman, MD, Onder Arslan, MD, Muhit Ozcan, MD, Meral Beksac, MD, Nahide Konuk, MD, Akin Uysal, MD, Haluk Koc, MD, Osman Ilhan, MD

Blood (2005) 106 (11): 4517.

https://doi.org/10.1182/blood.V106.11.4517.4517

Published: 2005

Journal Articles

Identification of Erythroid Cell Stimulating Factor as a Unique Protein, Quiescin Q6: Role in Erythropoiesis.

Kodetthoor B. Udupa, PhD, Chhanda Bose, PhD

Blood (2005) 106 (11): 4270.

https://doi.org/10.1182/blood.V106.11.4270.4270

Published: 2005

Journal Articles

A Bone Marrow Population Containing Both Hematopoietic and Mesenchymal Stem Cells Constitutively Expressing Genes Pairs For: SDF1-CXCR4, CX3CL-CXCR1 and for VEGF Improves Vascularization When Implanted to Ischemic Legs.

A. Lange, W. Witkiewicz, D. Dlubek, L. Maslowski, D. Drabczak-Skrzypek, E. Jaskula, B. Szymczak, D. Duda, J. Lange

Blood (2004) 104 (11): 4178.

https://doi.org/10.1182/blood.V104.11.4178.4178

Published: 2004

Journal Articles

First Report of the Phase III North American Trial of Decitabine in Advanced Myelodysplastic Syndrome (MDS).

Hussain Saba, Craig Rosenfeld, Jean-Pierre Issa, John DiPersio, Azra Raza, Virginia Klimek, James Slack, Carlos de Castro, Karl Mettinger, Hagop Kantarjian

Blood (2004) 104 (11): 67.

https://doi.org/10.1182/blood.V104.11.67.67

Published: 2004

NARROW

Preliminary Phase 2 Results Demonstrate Engraftment with Minimal Neutropenia with MGTA-456, a CD34 + Expanded Cord Blood (CB) Product in Patients Transplanted for Inherited Metabolic Disorders (IMD)

Prognostic Relevance of Monocytopenia and Lymphocyte-to-Monocyte Ratio in Primary Myelodysplastic Syndromes

Inhibition of the Histone Demethylase LSD1 Combined with Caloric Restriction or IGF1/Insulin Inhibition Leads to Durable Responses in a Preclinical Model of Acute Myeloid Leukemia

Defective WNT Signaling and Genetic Profile Of Endothelial Cells In Patients With Low Risk Myelodysplastic Syndromes Suggest a Contribution Of Vascular Niches To Myelodysplasia

Benefit of Extended Maintenance Therapy for Venous Thromboembolism with Dabigatran Etexilate Is Maintained Over 1 Year of Post-Treatment Follow-up

A Decision Analysis of Unrelated Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia In First Remission Who Lack An HLA-Matched Sibling

Combination of the KSP Inhibitor ARRY-520 with Bortezomib or Revlimid Causes Sustained Tumor Regressions and Significantly Increased Time to Regrowth in Models of Multiple Myeloma.

Results of Bone Marrow Examinations in Patients with Chronic Immune Thrombocytopenic Purpura Treated with Eltrombopag.

Venous Thromboembolism Risk in Stroke Patients Receiving Extended-Duration Enoxaparin Prophylaxis: Sub-Analysis of the EXCLAIM Study

Delayed Response to Lenalidomide in International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS).

Beneficial Effect of Zinc Supplementation on Oxidative Stress, Cytokines, and NF-κB DNA Binding in Sickle Cell Disease Patients.

A New Predictive and Prognostic Marker for De Novo AML: Peripheral Blood CD34 (pCD34) Count at Recovery Following Remission Induction (RI) Therapy (Supp. by Ankara University-2003-0809114).

Identification of Erythroid Cell Stimulating Factor as a Unique Protein, Quiescin Q6: Role in Erythropoiesis.

A Bone Marrow Population Containing Both Hematopoietic and Mesenchymal Stem Cells Constitutively Expressing Genes Pairs For: SDF1-CXCR4, CX3CL-CXCR1 and for VEGF Improves Vascularization When Implanted to Ischemic Legs.

First Report of the Phase III North American Trial of Decitabine in Advanced Myelodysplastic Syndrome (MDS).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only